Acquisition of monosomy 7 and a RUNX1 mutation in Pearson syndrome
暂无分享,去创建一个
S. Miyano | Y. Shiraishi | S. Ogawa | Kenichi Yoshida | H. Harigae | A. Manabe | D. Hasegawa | T. Fujiwara | S. Hirabayashi | Akira Nishimura | Miho Ashiarai | Yosuke Hosoya | Shinsuke Hirabayashi
[1] A. Borkhardt,et al. Hematological Presentation and Change in Clinical Phenotype during Follow-up in Pearson Syndrome , 2019, Blood.
[2] S. Tsunoda,et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers , 2019, Nature.
[3] M. Wlodarski,et al. Monosomy 7 in Pediatric Myelodysplastic Syndromes. , 2018, Hematology/oncology clinics of North America.
[4] Hiroaki Honda,et al. The enigma of monosomy 7. , 2018, Blood.
[5] S. Miyano,et al. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. , 2017, Blood.
[6] M. Wlodarski,et al. Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants , 2017, Leukemia.
[7] S. Miyano,et al. Dynamics of clonal evolution in myelodysplastic syndromes , 2016, Nature Genetics.
[8] J. Klco,et al. The genomic landscape of pediatric myelodysplastic syndromes , 2016, Nature Communications.
[9] Nicola D. Roberts,et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. , 2016, The New England journal of medicine.
[10] H. Okano,et al. SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7 , 2016, Nature Genetics.
[11] M. Fleming,et al. Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia. , 2014, Blood.
[12] A. Iwama,et al. Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation , 2014, Nature Communications.
[13] D. Steinemann,et al. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. , 2013, Blood.
[14] H. Kume,et al. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data , 2013, Nucleic acids research.
[15] I. Baumann,et al. Classification of childhood aplastic anemia and myelodysplastic syndrome. , 2011, Hematology. American Society of Hematology. Education Program.
[16] F. Sigaux,et al. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions. , 2011, Blood.
[17] Y. Beguin,et al. Cord blood transplantation in a child with Pearson's disease , 2008, Pediatric blood & cancer.
[18] G. Dini,et al. Allogeneic bone marrow transplantation for Pearson's syndrome , 2007, Bone Marrow Transplantation.
[19] J. Harbott,et al. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. , 2003, Blood.
[20] H. Kurahashi,et al. Fluorescence in situ hybridization analysis of peripheral blood cells in Pearson marrow-pancreas syndrome. , 2001, The Journal of pediatrics.
[21] Y. Goto,et al. The association between haematological manifestation and mtDNA deletions in Pearson syndrome , 1997, Journal of Inherited Metabolic Disease.
[22] N. Hamajima,et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. , 1997, Blood.
[23] A. Munnich,et al. MITOCHONDRIAL DNA DELETION IN PEARSON'S MARROW/PANCREAS SYNDROME , 1989, The Lancet.
[24] R. Hoffman,et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. , 1979, The Journal of pediatrics.
[25] M. Pillon,et al. Pearson Syndrome: A Retrospective Cohort Study from the Marrow Failure Study Group of A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica). , 2016, JIMD reports.
[26] M. A. O. Ignacio,et al. How to cite this article , 2016 .